Publications by authors named "Anna Senina"

Claim this Profile
L
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.
Mayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, Andres J Rubio, Christian Barreto-Vargas, Anna Senina

Clin Transl Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis.
Helong Zhao, Anthony D Pomicter, Anna M Eiring, Anca Franzini, Jonathan Ahmann, Anna Senina

Blood· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA.
Dongqing Yan, Anca Franzini, Anthony D Pomicter, Brayden J Halverson, Orlando Antelope, Anna V Senina

Blood Cancer Discov· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells.
Hein Than, Anthony D Pomicter, Dongqing Yan, Larry P Beaver, Anna M Eiring, Anna Senina

Leukemia· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants.
Christopher A Eide, Matthew S Zabriskie, Samantha L Savage Stevens, Orlando Antelope, Nadeem A Vellore, Anna V Senina

Cancer Cell· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear-Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis.
Dongqing Yan, Anthony D Pomicter, Srinivas Tantravahi, Clinton C Mason, Anna V Senina

Clin Cancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion.
William L Heaton, Anna V Senina, Anthony D Pomicter, Mohamed E Salama, Phillip M Clair

Leukemia· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolysis by paramyxoviruses: preclinical and clinical studies.
Olga V Matveeva, Zong S Guo, Vyacheslav M Senin, Anna V Senina, Svetlana A Shabalina

Mol Ther Oncolytics· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited efficacy of BMS-911543 in a murine model of Janus kinase 2 V617F myeloproliferative neoplasm.
Anthony D Pomicter, Anna M Eiring, Anna V Senina, Matthew S Zabriskie, James E Marvin

Exp Hematol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.
Anna M Eiring, Brent D G Page, Ira L Kraft, Clinton C Mason, Nadeem A Vellore, Anna Senina

Leukemia· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A small-molecule inhibitor of PIM kinases as a potential treatment for urothelial carcinomas.
Jason M Foulks, Kent J Carpenter, Bai Luo, Yong Xu, Anna Senina

Neoplasia· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic activation of PKM2 slows lung tumor xenograft growth.
K Mark Parnell, Jason M Foulks, Rebecca N Nix, Adrianne Clifford, Jeremy Bullough, Anna Senina

Mol Cancer Ther· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis